<SEC-HEADER>0000950170-24-059596.hdr.sgml : 20240514
<ACCEPTANCE-DATETIME>20240514162033
<ACCESSION-NUMBER>0000950170-24-059596
<TYPE>10-Q
<PUBLIC-DOCUMENT-COUNT>39
<PERIOD>20240331
<FILING-DATE>20240514
<DATE-OF-FILING-DATE-CHANGE>20240514
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>Evoke Pharma Inc
<CIK>0001403708
<ASSIGNED-SIC>2834
<ORGANIZATION-NAME>03 Life Sciences
<IRS-NUMBER>208447886
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>10-Q
<ACT>34
<FILE-NUMBER>001-36075
<FILM-NUMBER>24944677
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>420 STEVENS AVENUE
<STREET2>SUITE 370
<CITY>SOLANA BEACH
<STATE>CA
<ZIP>92075
<PHONE>858-345-1494
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>420 STEVENS AVENUE
<STREET2>SUITE 370
<CITY>SOLANA BEACH
<STATE>CA
<ZIP>92075
</MAIL-ADDRESS>
</FILER>
</SEC-HEADER>
